Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Potassium chloride + sodium lactate + sodium chloride + dextrose monohydrate + calcium chloride is a marketed multi-electrolyte intravenous crystalloid and carbohydrate solution used for parenteral replacement of extracellular fluid and electrolyte losses and as a source of water, electrolytes, and calories. It is marketed as Potassium Chloride in Lactated Ringer's and Dextrose 5% Injection and related Lactated Ringer's and Dextrose products, including by Hospira and ICU Medical. The formulation contains five active ingredients and acts through physiologic replacement rather than receptor-selective pharmacology: sodium, potassium, calcium, chloride, and lactate help restore extracellular fluid and electrolyte balance, while dextrose provides carbohydrate calories and lactate serves as a bicarbonate precursor with an alkalinizing effect. It is indicated as a fluid and electrolyte replacement solution and alkalinizing agent in adults and pediatric patients requiring intravenous or parenteral administration.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on potassium chloride + sodium lactate + sodium chloride + dextrose monohydrate + calcium chloride.